Published online Apr 28, 2021. doi: 10.3748/wjg.v27.i16.1816
Peer-review started: January 31, 2021
First decision: February 22, 2021
Revised: March 5, 2021
Accepted: April 13, 2021
Article in press: April 13, 2021
Published online: April 28, 2021
Processing time: 79 Days and 16.8 Hours
With improved survival in gastric cancer patients, health-related quality of life has become an important clinical endpoint alongside primary oncological outcomes.
To investigate health-related quality of life after various surgical procedures for gastric cancer treatment.
The validated Slovenian version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (QLQ-C30) and its gastric cancer-specific module (QLQ STO-22) was sent for self-completion to patients that underwent curative resection for gastric adenocarcinoma between January 2014 and December 2018 at our centre. In total, 116 patients responded. Scores were compared between patients after subtotal distal vs total gastrectomy and patients after subtotal distal gastrectomy with Billroth II vs Roux-en-Y reconstruction.
Interestingly, the extent of resection did not influence daily functioning; however, more dysphagia and eating restrictions were reported in patients after total gastrectomy when compared to patients after subtotal distal gastrectomy. Moreover, patients with Billroth II reconstruction after subtotal distal resection experienced worse physical and role functioning and reported more pain, fatigue and reflux compared to Roux-en-Y reconstruction.
Based on our results, Roux-en-Y reconstruction after subtotal distal gastrectomy should be preferred over Billroth II reconstruction. The data obtained from this study will help surgeons when preoperatively informing their patients about expected functional outcomes after gastrectomy and enable them to ensure proper supportive care of their patients in the postoperative period.
Core Tip: Quality of life assessment is an important tool to guide and evaluate treatment interventions, especially after a major surgery like gastrectomy. We conducted a cross-sectional survey among patients with gastric adenocarcinoma treated at our centre to provide insight into overall wellbeing after curative resection. The information provided will guide surgeons in selecting an optimal treatment approach and informing patients about expected treatment outcomes.